Bioceltix SA

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PLBCLTX00019
PLN
78.10
3.6 (4.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Bioceltix SA Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-14.00
-13.00
-8.00
-4.00
-2.00
-1.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-3.00
-1.00
0.00
0.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-17.00
-14.00
-7.00
-4.00
-1.00
-1.00
Cash Flow from Investing Activities
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Financing Activities
42.00
20.00
6.00
6.00
3.00
1.00
Net Cash Inflow / Outflow
24.00
5.00
-1.00
2.00
2.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in PLN Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Bioceltix SA
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(PLN)
Change(%)
Profit Before Tax
-14.86740931
-31.287928
17.00
52.48%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-3.36144076
-27.32509
24.00
87.70%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-17.73624911
-56.989299
39.00
68.88%
Cash Flow from Investing Activities
-0.08424374
-23.570534
23.00
99.64%
Cash Flow from Financing Activities
42.14305076
34.759895
8.00
21.24%
Net Cash Inflow / Outflow
24.32255791
-45.799938
69.00
153.11%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -20.00% vs -86.94% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-17.74
-14.78
-20.00%